Holen Sie sich die Stockscreener-App
4.42
0.00%
0.00
Handel nachbörslich:
4.36
-0.06
-1.36%
Cellectar Biosciences Inc Aktie (CLRB) Neueste Nachrichten
Cellectar Biosciences Q2 2025 Earnings Call Transcript - MarketBeat
Cellectar's 2025 Q2 Earnings Call: Key Contradictions in Phase 3 Trial Strategy and Cost Projections - AInvest
All You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy - MSN
Earnings call transcript: SelectR Biosciences Q2 2025 reports $5.4M loss - Investing.com
Cellectar Cuts Q2 Losses and Expenses - The Globe and Mail
Cellectar Biosciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire
Cellectar's Blood Cancer Drug Gets FDA Breakthrough Status, Eyes Accelerated Approval Path - Stock Titan
Cellectar Biosciences, Inc. SEC 10-Q Report - TradingView
Why Cellectar Biosciences Inc. stock attracts strong analyst attentionTrade Risk Report & Weekly Top Gainers Trade List - Newser
Cellectar Biosciences Q2 2025 Earnings Preview: Analysts Expect $-3.66 EPS - AInvest
How to manage a losing position in Cellectar Biosciences Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - Newser
Published on: 2025-08-13 08:37:11 - Newser
What’s next for Cellectar Biosciences Inc. stock priceIndex Update & Long-Term Growth Plans - Newser
Cellectar Biosciences Inc. stock chart pattern explained2025 Market Overview & Long-Term Growth Portfolio Plans - Newser
Will Cellectar Biosciences Inc. see short term momentumJuly 2025 Short Interest & AI Powered Market Entry Strategies - Newser
How to recover losses in Cellectar Biosciences Inc. stockSummary of Trade Cycles in 5-Year Range - Newser
What moving averages say about Cellectar Biosciences Inc.Free Investment Strategy With Low Risk - Newser
Multi factor analysis applied to Cellectar Biosciences Inc.High Return Trade Roadmap with Setup Filters - Newser
Cellectar Biosciences Inc. stock trend forecastTechnical Trend Forecast for Investors - Newser
What recovery options are there for Cellectar Biosciences Inc.Daily Stock Movement Forecast with Accuracy - Newser
A | What is Cellectar Biosciences, Inc.'s revenue forecastBest ROI Stock Strategies - newsyoung.net
Will a bounce in Cellectar Biosciences Inc. offer an exitPattern Recognition Tool for ROI Investors - Newser
Key metrics from Cellectar Biosciences Inc.’s quarterly dataFree Trade Ready Stock Watch for Short Term - Newser
Cellectar Biosciences reports Q2 financial results, conference call on August 14. - AInvest
Cellectar Biosciences to Unveil Q2 2025 Financial Results and Key Corporate Updates Next Week - Stock Titan
Ewing Sarcoma Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Nanovalent Pharma, Oncomatryx, Valent Technologies, Cellectar Biosciences, Eisai Inc - Barchart.com
Cellectar Biosciences Inc. Shows Early Signs of Technical StrengthInvestment Plan With Growth Optimization Finalized - metal.it
Is it the right time to buy Cellectar Biosciences Inc. stockInvest in stocks with long-term growth potential - Jammu Links News
When is Cellectar Biosciences Inc. stock expected to show significant growthGet real-time updates on market trends - Jammu Links News
Is Cellectar Biosciences Inc. stock overvalued or undervaluedExtraordinary market timing - Jammu Links News
What makes Cellectar Biosciences Inc. stock price move sharplyExceptional profit velocity - Jammu Links News
Published on: 2025-08-03 14:24:10 - Jammu Links News
How does Cellectar Biosciences Inc. generate profit in a changing economyRapid wealth creation - Jammu Links News
What are analysts’ price targets for Cellectar Biosciences Inc. in the next 12 monthsRecord-setting profit potential - Jammu Links News
Is Cellectar Biosciences Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
Should I hold or sell Cellectar Biosciences Inc. stock in 2025Invest smarter with daily trading signals - Jammu Links News
What are the latest earnings results for Cellectar Biosciences Inc.Get professional advice for portfolio optimization - Jammu Links News
Oragenics' Stock Takes A Hit With New Offering Announcement - Finimize
What’s the recovery path for long term holders of Cellectar Biosciences Inc.Market Momentum and Signal Alerts Suggest Reversal - metal.it
Cellectar Biosciences Inc.’s Price Action Aligns with Quant SignalsFree Stock Market Practical Discussion Forums - beatles.ru
Cellectar Biosciences Inc. Could See a Relief Rally From SupportExit Ready Momentum Stock Watchlist Expanded - metal.it
Screener Results Flag Cellectar Biosciences Inc. as OversoldConsistent Gain Investment Strategies Emerge - metal.it
Published on: 2025-07-29 16:45:28 - metal.it
How high can Cellectar Biosciences Inc. stock goWeekly Setup Summary for Risk Controlled Trades - Newser
Why did Cellectar's operating expenses surge in Q4 2024? - AInvest
Published on: 2025-07-29 04:25:46 - Newser
Technical analysis overview for Cellectar Biosciences Inc. stockSwing Candidate List with Trade Cues - Newser
Cellectar Biosciences Inc. Builds Base for Possible ReboundFast Exit and Entry Strategy Guide Offered - metal.it
Why is Cellectar Biosciences Inc. stock attracting strong analyst attentionExpert Picks Outlook To Watch Now - Jammu Links News
How to manage a losing position in Cellectar Biosciences Inc. Predictive Screener for Daily Trade Watch - Newser
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):